Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial steps of atherosclerosis through inhibition of the MAPK pathway by Catalán Santos, Úrsula et al.
Document downloaded from:
http://hdl.handle.net/10459.1/71571
The final publication is available at:
https://doi.org/10.1016/j.jff.2017.11.007
Copyright
cc-by-nc-nd, (c) Elsevier, 2018
Està subjecte a una llicència de


































































1 of 41 
Hydroxytyrosol and its main plasma circulating metabolites attenuate the initial 1 






















Functional Nutrition, Oxidation and Cardiovascular Diseases Group (NFOC-Salut), 8 
Hospital Universitari Sant Joan (HUSJR), Institut d’Investigació Sanitaria Pere Virgili 9 
(IISPV), Technological Center of Nutrition and Health (CTNS), Faculty of Medicine 10 
and Health Sciences, Universitat Rovira i Virgili, Sant Llorenç, 21, 43201, Reus, Spain 11 
2 
Food Technology Department, Universitat de Lleida-AGROTECNIO Center, Alcalde 12 
Rovira Roure 191, 25198 Lleida, Spain 13 
3
 Department of Medicine, Facultat de Medicina, University of Lleida, Avda/Alcalde 14 
Rovira Roure 80, 25198 Lleida, Spain 15 
16 
†Correspondence: 17 
Laura RUBIÓ, PhD 18 
E-mail address: laura.rubio@iispv.cat 19 
and 20 
Maria-José MOTILVA, PhD 21 
E-mail: motilva@tecal.udl.cat 22 
23 
Keywords: Hydroxytyrosol; hydroxytyrosol metabolites; atherosclerosis; ApoE
-/-
 mice; 24 
human aortic endothelial cells25 
*Manuscript



































































2 of 41 
Abstract 26 
The main aim of this work is to gain insight into the potential mechanisms of 27 
hydroxytyrosol (HT) and its main plasmatic metabolites (HTmet) that improve the 28 
endothelial function. Feeding ApoE
-/-
 mice with 10 mg/kg/day of HT derivatives for 12 29 
weeks significantly reduced E-selectin, VCAM-1, MCP-1, ICAM-1, and F4/80 30 
expression compared with the control group in the isolated aorta. Further in-vitro 31 
mechanistic assays revealed that both HT and HTmet could reduce the adhesion of 32 
Jurkat-T-lymphocytes to human aortic endothelial cells at 1-5 µM, significantly greater 33 
reductions being observed with HTmet. This process appeared to be regulated by the 34 
MAPK pathway through the inactivation of p38δ, JNK1-3, CREB, AKT3, p53 and P70 35 
S6 Kinase. We concluded that supplementation with HT precursors from olive oil might 36 
attenuate the initial step of atherosclerosis at a molecular level. The reduction of 37 
lymphocyte adhesion and the modulation of MAPK pathway by HTmet could explain 38 
this phenomenon. 39 
 40 
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1. Introduction 48 
Cardiovascular diseases (CVD) contribute significantly to the mortality, morbidity and 49 
economic burden of illness and their prevention by dietary strategies has become a 50 
significant public health challenge. Chronic exposure to cardiovascular risk factors 51 
overwhelms the defence mechanisms of the vascular endothelium, hence compromising 52 
its integrity and ultimately initiating endothelial dysfunction (Chhabra, 2009).  So, as 53 
this dysfunction is an initial and reversible step of atherosclerotic disease, inhibiting it is 54 
a possible approach to preventing CVD. Over recent years, the number of studies on 55 
food bioactive compounds as potential modulators of the endothelial function has risen 56 
(Rangel-Huerta, Pastor-Villaescusa, Aguilera, & Gil, 2015), given that the endothelium 57 
is exposed to these molecules or their biological metabolites in the bloodstream after 58 
absorption (Catalán et al., 2015).  59 
 Virgin olive oil (VOO), the leading source of fat in the Mediterranean diet, has 60 
been shown to protect against CVD (López-Miranda et al., 2010; Urpi-Sarda et al., 61 
2012). This has mainly been related to its phenolic fraction. Hydroxytyrosol (HT) and 62 
its derivatives known as secoiridoids (SEC) are the most abundant and widely-studied 63 
olive oil phenolic compounds (OOPCs). Many beneficial effects have been attributed to 64 
HT. Its alleged anti-inflammatory, antioxidant, anti-cancer or endothelial and vascular 65 
functions have been studied in cells, animals, and humans (Echeverría, Ortiz, 66 
Valenzuela, & Videla, 2017). Recent animal studies showed that HT supplementation 67 
prevents metabolic alterations in desaturase activities, oxidative stress status and the n-3 68 
long chain polyunsaturated fatty acid contents of the liver and extrahepatic tissues of 69 
mice fed a high-fat diet (HFD) (Valenzuela, Echeverria, et al., 2017). These metabolic 70 
alterations of the liver are regulated by activating the PPAR-α and Nrf2 transcription 71 
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Illesca, et al., 2017). In human studies, supplementing the diet with VOO rich in 73 
polyphenols improved the antioxidant and anti-inflammatory status and reduced the 74 
expression of cell adhesion molecules, compared with low-polyphenol VOO (Covas, 75 
2007; López-Miranda et al., 2010). Other studies have shown that the endothelial 76 
function can be enhanced by consuming high-phenolic VOO in hypercholesterolemic 77 
(Juan Ruano et al., 2005) and hypertensive patients (Moreno-Luna et al., 2012; Valls et 78 
al., 2015).  79 
 After the daily consumption 5 mg of HT and its derivatives through 20 g of 80 
VOO, the dose required by the European Food Safety Authority (EFSA) for 81 
cardiovascular protection (“European Community, Council Regulation No. 432/2012 of 82 
16 May 2012 establishing a list of permitted health claims made on foods, other than 83 
those referring to the reduction of disease risk, to children’s development, health.,” 84 
2012), the native form of HT is not detected in plasma. It was observed that sulfation 85 
was the major pathway for HT metabolism in humans (Rubió et al., 2014). Therefore, 86 
the potential health benefits of OOPCs could be attributed to the biological activity of 87 
phase-II metabolites rather than the native form of HT. 88 
In our previous study, a novel approach was developed using Caco-2 cells as 89 
bioreactors to enable a mixture of HT metabolites (HTmet) to be obtained with a 90% 90 
resemblance to human plasma after dietary doses of VOO (Catalán et al., 2015). In this 91 
study, HT metabolites were incubated with human aortic endothelial cells (HAEC), and 92 
a dose-dependent inhibition of the endothelial dysfunction biomarkers E-selectin, P-93 
selectin, vascular cell adhesion molecule-1 (VCAM-1) and the intracellular cell 94 
adhesion molecule-1 (ICAM-1) was observed (Catalán et al., 2015). Additionally, a 95 
more significant effect of HT metabolites was observed in the reduction of the 96 
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These data provided evidence of the potential effect of HT phase-II metabolites in 98 
improving the endothelial dysfunction. However, the involvement of the circulating HT 99 
metabolites in the intracellular pathways of adhesion molecule secretion in the 100 
endothelial function has yet to be studied. 101 
In the present work, the ApoE
-/-
 mice model was supplemented with an olive 102 
phenolic extract rich in SEC at a nutritionally appropriate dose (10 mg/kg/day) to assess 103 
the improvement of the endothelial function in the initial steps of atherosclerosis. We 104 
conducted an in-vitro functional assay to study the mechanisms using physiological 105 
concentrations of HT and HTmet through the adhesion of lymphocytes to HAEC. For 106 
deeper insight into the molecular mechanisms, we evaluated the modulation of the 107 
mitogen-activated protein kinase (MAPK) family pathway and nuclear factor kappa-108 
light-chain-enhancer of activated B cells (NF-κB). The potential post-transcriptional 109 
effects through the mRNA expression and stability of the VCAM-1, ICAM-1, E-110 
selectin and MCP-1 molecules were also assessed. 111 
2. Materials and Methods 112 
2.1. Solvents and reagents 113 
 HT (99.5% purity) was purchased from Seprox Biotech (Madrid, Spain). 114 
Hydroxytyrosol-3’-O-sulfate was acquired from Toronto Research Chemicals Inc. 115 
(Toronto, Ontario, Canada) according to the method reported by Khymenets et al. 116 
(Khymenets et al., 2006). Methanol (HPLC-grade) and acetonitrile (HPLC-grade) were 117 
purchased from Scharlab (Barcelona, Spain) and orthophosphoric acid (85%) from 118 
Panreac (Barcelona, Spain). Milli-Q water was obtained from a Milli-Q water 119 
purification system (Millipore Corp., Medford, MA, USA).  120 
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10 male and 10 female 6-week-old Apolipoprotein E knockout mice were 122 
purchased from Charles River Laboratories (Barcelona, Spain) and distributed between 123 
the control (4 male and 4 female) and secoiridoid (SEC) treatment groups (6 male and 6 124 
female). The animals were maintained in regular temperature-controlled rooms (25 ± 2 125 
°C) with controlled lighting (12 h light–dark cycles). The control mice received a 126 
standard isocaloric and isonitrogenous diet (Envigo, Harlan Laboratories, Madison, WI, 127 
USA). The SEC group diet was prepared weekly with a standard crushed diet mixed 128 
with Milli-Q water containing SEC extract with a dose equivalent to 10 mg of SEC/kg 129 
weight. The pellets were freeze-dried and stored at −20 ºC until use. The feed and 130 
animals were weighed every two days to adjust the weekly dose. After 12 weeks of 131 
treatment, the animals were kept in metabolic cages for 24 h to collect their urine and 132 
faeces. After that, they were anesthetized with isoflurane (IsoFlo, Veterinarian Esteve, 133 
Bologna, Italy) and sacrificed by exsanguination. Blood was collected in EDTA tubes 134 
(Vacutainer Tubes, BD, Franklin Lakes, NJ, USA) and plasma samples were obtained 135 
by centrifuging (3000 g, 10 min at 4ºC). The aorta was removed, rinsed with phosphate-136 
buffered saline buffer and thoroughly cleaned of adventitial fat using surgical material 137 
under a stereoscopic microscope. The whole aorta was then immersed-fixed in 4% 138 
paraformaldehyde at 4ºC for 24 h.  139 
The investigation was approved by the Animal Ethics Committee (7688) at the 140 
Universitat of Lleida (CEEA 17
th
 February 2015) and the procedure was conducted in 141 
line with the guidelines of the European Communities Directive 2010/63/EU. 142 
2.3. Preparation of the SEC phenolic extract 143 
 SEC extract from olive cake was prepared as previously reported (Khymenets et 144 
al., 2006) with some modifications. Briefly, 10 g of freeze-dried olive cake was mixed 145 
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Dionex, Sunnyvale, CA, USA). The solvent conditions were Ethanol/water (80:20), at 147 
80ºC, 60% setting volume, and two 5-min static cycles. The ethanol was then 148 
eliminated by rotary evaporation. The aqueous extract was adjusted to pH=4 with acetic 149 
acid and then purified using the SPE method (OASIS HLB Elution cartridges 6 g, 150 
Waters, Milford, MA, USA). Cartridges were activated with 35 mL methanol, 151 
equilibrated with 40 mL of water pH=2, and loaded with 50 mL of ASE liquid extract., 152 
30 mL of Milli-Q water was used to clean up followed by 20 mL of methanol 5% (v/v). 153 
Finally, the retained phenolic compounds were eluted with 60 mL of ethanol, and then 154 
rotary evaporated until the ethanol was totally evaporated (Buchi Rotavapor, DE, USA). 155 
An aliquot of the aqueous extract was analyzed by UPLC-MS/MS using the 156 
chromatographic method we reported previously (Rubió, Motilva, Macià, Ramo, & 157 
Romero, 2012). The phenolic composition of the extract used is available in 158 
Supplementary Table 1. To calculate the administered dose of 10 mg/kg weight of 159 
SEC, only 3,4-DHPEA-EDA was considered as the main secoiridoid derivate providing 160 
HT.  161 
2.4. Analysis of phenolic compliance biomarkers in ApoE-/- 162 
 Urine samples collected before sacrifice were pre-treated using microelution 163 
solid-phase extraction (µSPE) (OASIS -HLB μElution plates 30 μm Waters, Milford, 164 
MA, USA) according to the method developed previously (Serra et al., 2013). The 165 
faeces were freeze-dried and pre-treated as previously described (López de las Hazas et 166 
al., 2016). The phenolic compounds in the urine and faeces were analyzed by Acquity 167 
Ultra-PerformanceTM liquid chromatography coupled to tandem MS as the detector 168 
system (UPLC-MS/MS) from Waters (Milford MA, USA), as reported in our previous 169 
study (López de las Hazas et al., 2016). The SRM conditions for the analysis of the 170 
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2.5. Measurement of atherosclerotic lesion by oil red O staining 172 
 ApoE
-/-
 mice aortas were stained with oil red to visualize neutral lipid 173 
accumulation. The immersion-fixed aortas were rinsed twice with 78% methanol and 174 
then submerged in 0.2% oil red solution (Sigma-Aldrich, Madrid, Spain) for 1 hour. 175 
After rinsing with 78% methanol, the aortic arch was cut open, and images of the oil red 176 
O-stained aortas were taken. 177 
2.6. Histopathology staining 178 
For Haematoxylin-Eosin, Masson trichrome and Alcian blue staining, the aortas 179 
were dehydrated following a cycle of different ethanol concentrations and then 180 
submerged in xylol. The samples were embedded in paraffin and sectioned into 5 µm 181 
and then deparaffinized and rehydrated in xylene and ethanol/water mixtures to perform 182 
the staining. Lesion areas were estimated using measurements from cryosections of the 183 
aortic base with the aid of the Photoshop CS6 (Adobe Systems Software, Ireland) and 184 
the ImageJ (Free software programmed in Java, public domain). 185 
2.6.1. Haematoxylin-eosin 186 
Haematoxylin-eosin staining was used to assess the integrity of the aorta. 187 
Hydrated histological cuts were incubated for 15 min with Harris’s hematoxylin, 188 
washed with water and submerged in acid alcohol for 5 min. After rinsing with tap 189 
water, the samples were immersed in eosin (1%) for 5 min., and finally dehydrated by 190 
submerging for 5 min in ethanol, xylol, and xylol-eucalyptol (1:1) respectively to 191 
assemble the acrylic resin. 192 
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Masson trichrome was used to study the collagen deposition and fibrosis in the 194 
arterial wall. Sections of rehydrated samples were submerged in Bouin’s fixative (picric 195 
acid, formaldehyde and acetic acid (71,5/24/4,5 %) for 1 h at 56ºC. The samples were 196 
then washed with tap water until the yellowness disappeared. After that, the slides were 197 
submerged in Weigert Haematoxylin (haematoxylin 1% in ethanol + ferric clorure 20% 198 
in acid water) for 5 min, then washed with tap water and submerged in trichromic 199 
solution (light green with chromotropic and phosphotungstenic acid in water) for 10 200 
min. After that, they were washed with distilled water and then immersed in light green 201 
colorant (2%) for 5 min. before being quickly washed with distilled water. Finally, the 202 
samples were dehydrated with ethanol (by submerging and taking out the samples), 203 
submerging with xylol (10min) and xylol-eucaliptol (1:1) for 10 min before mounting 204 
them. 205 
2.6.3. Alcian Blue 206 
Alcian blue staining was performed to assess the proteoglycan deposited on the 207 
aorta wall. Deparaffinized slide samples were submerged in Alcian blue (1%; pH=2,5 208 
with acetic acid) for 30 min, before being washed firstly with tap water for 2 min and 209 
then with distilled water. After that, these samples were submerged in red nuclear 210 
(0.1%) for 5 min followed by 1 min of water rinsing. Finally, they were dehydrated by 211 
submerging them for 5 min in ethanol, xylol, and xylol-eucalyptol (1:1) respectively to 212 
assemble the acrylic resin. 213 
2.7. Serum biomarkers  214 
 Serum total cholesterol (TC), triglycerides (TG), high-density lipoprotein 215 
cholesterol (HDLc) and glucose were measured by standardized methods using the 216 
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cholesterol (LDLc) was calculated with the Friedewald formula (Friedewald, Levy, & 218 
Fredrickson, 1972). TC, TG, HDLc, Glucose, and LDLc are expressed as mg/dL. 219 
2.8. Immunohistochemistry assay of VCAM-1, E-selectin, MCP-1, ICAM-1, and F4/80 220 
in mice aortic sections  221 
 VCAM-1, E-selectin, MCP-1, ICAM-1, and F4/80 were selected as 222 
representative adhesion molecules for the immunohistochemistry assay. Formalin-fixed 223 
aorta sections (5 µm) were obtained from the descending thoracic aorta, 3 mm distal to 224 
the left subclavian artery. The paraffin-embedded aorta was dewaxed and stained with 225 
anti-VCAM-1 and anti-E-selectin antibodies (Abcam ab134047 and ab185698 226 
respectively; Cambridge, United Kingdom), ICAM-1 (sc-8439; Santa Cruz 227 
Biotechnology, Heidelberg, Germany) and F4/80 (MCA497RT; Bio-Rad Laboratories 228 
S.A., El Prat de Llobregat, Barcelona). The aorta samples were incubated in 10 mM 229 
citrate buffer in the microwave oven for 20 min for antigen retrieval or proteinase K 20 230 
µg/mL at 37ºC for F4/80, before applying a 1:200 dilution of anti-VCAM-1, 1:100 231 
dilutions of anti-E-selectin and ICAM-1, and 1:1000 dilution of anti-F4/80 overnight at 232 
4ºC. To detect the MCP-1 antibody (Abcam ab25124; Cambridge, United Kingdom), 233 
the samples were incubated with the primary antibody (10 µg/mL) for 30 min. After 234 
washing with PBS, the samples were incubated in biotinylated rabbit anti-goat antibody 235 
for 60 min at 37°C. Staining was processed and visualized with ChemMate™ DAKO 236 
EnVision™ Detection Kit, Peroxidase/DAB, Rabbit/Mouse Code-Nr. K 5007 (Agilent 237 
Technologies, Madrid, Spain) according to the manufacturer’s instructions.  238 
Scoring of VCAM-1, E-selectin, MCP-1, ICAM-1, and F4/80 in the aorta was based on 239 
a semi-quantitative analysis previously used by Matsui R, et al. (Matsui et al., 2006). 40 240 
photographs of immuno-stained Apo E-/- mouse aorta were taken under the microscope 241 



































































11 of 41 
(Grade 0 to 3) were given to the aortic tunica intima, media and adventitia according to 243 
the intensity of the staining (from 0 for low intensity to 3 for high intensity). The 244 
averages of the scores for each photograph given by the three observers were taken as 245 
the scores for the samples. 246 
2.9. Biosynthesis, purification, and analysis of HT metabolites 247 
 Biosynthesis of the main plasmatic metabolites of HT was performed through 248 
Caco-2 cells as previously described (Catalán et al., 2015) to obtain a purified extract 249 
that resembled human plasma after VOO intake. Briefly, based on the biotransformation 250 
yield of HT into phase-II metabolites, after 24 h in T75 flasks, differentiated Caco-2 251 
cells were exposed to 100 µM of HT. The metabolites obtained were HT sulfate (80%), 252 
homovanillic alcohol sulfate (10%) and, in a lesser proportion, HT glucuronides, and 253 
free HT. Before chromatographic analysis (see Section 2.4), the HT and its metabolites 254 
were isolated from the cell media using µSPE plates (Waters Corp., Milford, MA, USA) 255 
according to the previous study (Catalán et al., 2015). The phenolic composition was 256 
analyzed by an AcQuity UPLCTM coupled to a photodiode array detector detector and 257 
a triple quadrupole detector (TQD)TM mass spectrometer (Waters, Milford) with the 258 
chromatographic conditions previously reported (Catalán et al., 2015). HT and HT-3-O-259 
sulphate were quantified with their calibration curves, and the other HTmet were 260 
tentatively quantified by using the calibration curve of HT. The calibration curves were 261 
constructed by using cellular medium free of HTmet. 262 
2.10. Cell culture 263 
2.10.1. Human aortic endothelial cells 264 
 HAEC (Cascade Biologics™, Portland, OR, USA) at the fifth passage were 265 
seeded on Nunclon™ Δ surface 12-well plates at a density of approximately 44 × 10
3
 of 266 
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cm dishes (for the MAPK proteome profiler and NF-κB activity assays). For the first 268 
24 h, the cells were maintained in complete cell culture medium (CM) composed of M-269 
200 medium supplemented with 2% (v/v) low-serum growth supplement, 10 mg/mL 270 
gentamicin, 0.25 mg/mL amphotericin B (purchased from Gibco by Life Technologies, 271 
Madrid, Spain), 100 U/mL penicillin and 100 mg/mL of streptomycin (from Biowest-272 
Labclinics, Barcelona, Spain). The cells were grown to confluence at 37°C in a 273 
humidified incubator (Heracell 150; Madrid, Spain) with an atmosphere containing 5% 274 
CO2. The medium was replenished every 2 days with new CM. Viewed under an IMT2 275 
microscope (Olympus, Barcelona, Spain), confluent monolayers displayed a typical 276 
monolayer phenotype of quiescent endothelial cells after 5 days in culture. 277 
 Experiments of time and dose-response were conducted to establish the final 278 
conditions of TNF-α (Calbiochem, Darmstadt, Germany) as a stimulant. The stock 279 
solutions used in the experiments were: 5 mM of HT (commercial; Seprox BIOTECH, 280 
Madrid, Spain) dissolved in sterile H2O and tetraacetic mM of the purified solution of 281 
HT metabolites dissolved in methanol (Panreac, Madrid, Spain). Appropriate dilutions 282 
were prepared until the final concentrations for the culture media (0.5, 1, 2 and 5 μM) 283 
were obtained. To preempt cell cytotoxicity, methanol concentrations never exceeded 284 
0.1% (v/v) in the culture media. Then, for the mRNA assays or adhesion assays, the 285 
HAECs were co-incubated with HT or HT metabolites at 0.5, 1, 2 and 5 μM and TNF-α 286 
(10 ng/mL), the respective vehicle control alone (sterile H2O for HT or absolute 287 
methanol for HT metabolites) or TNF-α alone (10 ng/mL) for 24h. For the MAPK 288 
proteome profiler or NF-κB activity assays, HAECs were co-incubated with HT or HT 289 
metabolites 5 μM and TNF-α (10 ng/mL), blank (cells alone) or TNF-α alone (10 290 
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The cytotoxicity effect of HT or HT metabolites on the HAECs was assessed with a 292 
Cytotoxicity Detection Kit LDH (Roche Applied Science, Mannheim, Germany) 293 
described in a previous study by the group (Catalán et al., 2015). 294 
2.10.2. Jurkat T cell lymphocytes 295 
 Jurkat T cell lymphocytes were purchased from DSMZ GmbH (Braunschweig, 296 
Germany). These were cultured in an RPMI medium 1640 + Glutamax-I (Gibco, Spain) 297 
supplemented with 20% heat-inactivated foetal bovine serum (FBS) (PAA, Labclinics,) 298 
for the first 2 days, followed by 10% FBS + 100 U/mL penicillin and 100 mg/mL 299 
streptomycin for growth and the scheduled experiments. The Jurkat T cells were 300 
maintained until the cell-cell adhesion assays. 301 
2.11. Functional Adhesion Assay 302 
2.11.1. Calcein Labeling of Jurkat T Cells 303 
 Calcein acetoxymethyl ester (calcein-AM, Molecular Probes, Eugene, Oregon, 304 
USA) was used to fluorescently label the Jurkat T cells. Calcein is nonfluorescent, and 305 
the lipophilic molecule which is cleaved by endogenous esterases and the resulting 306 
product’s fluorescence can be measured at 485 and 530 nm (excitation and emission 307 
wavelengths respectively). The Jurkat T cells were fluorescently labeled by incubating 308 
cells (5x106 cells/mL) with a final concentration of 5 µM of calcein-AM for 30 min at 309 
37 °C and 5% CO2. After loading the calcein-AM, the cells were washed twice with an 310 
RPMI-1640 medium supplemented with 10% FBS to remove excess dye. The cells 311 
were finally resuspended in CM at a density of 2.5 x 10
6
 cells/mL. 312 
2.11.2. Cell-cell adhesion 313 
 HAECs were seeded until confluence in black 96-well tissue culture plates 314 
following the appropriate culture conditions with blank (cells alone), TNF-α (10ng/mL) 315 
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Then calcein-AM-labeled Jurkat T cells were cocultured (2.5 x 105 cells/well) with the 317 
HAEC monolayer for 1 h at 37°C in a humidified atmosphere with 5% CO2. The 318 
nonadherent Jurkat T cells were removed from the HAEC monolayer by washing it 319 
twice with CM. The fluorescence intensity in each well of the culture plate was 320 
measured with the Synergy HT Fluorometer (BioTek Instruments, Alcobendas, Spain). 321 
The results are expressed as relative fluorescence units and SD (error bars). 322 
2.12. Analysis of adhesion molecule mRNA expression by real-time quantitative reverse 323 
transcriptase polymerase chain reaction in HAEC 324 
 The HAECs were lysed with Lysis Buffer containing 1% 2-mercaptoethanol, 325 
and the total RNA was purified from the cells using a PureLink RNA Mini Kit from 326 
Ambion (Life Technologies, Madrid, Spain) according to the manufacturer’s protocol. 327 
Total RNA was quantified using a Quant-it TM RNA Assay Kit and Qubit TM 328 
fluorometer (Invitrogen). Using the 2720 Thermal Cycler (Applied Biosystems), 0.5 µg 329 
of the total RNA was reverse transcribed to cDNA at 42°C for 50 min using random 330 
hexamers; SuperScript II reverse transcriptase and RNase Out (Invitrogen) according to 331 
the manufacturer’s protocol. To determine the amounts of VCAM-1, E-selectin, ICAM-332 
1 and MCP-1 mRNA, semiquantitative RT-PCR was performed using the ABI PRISM 333 
7900 Detection System (Applied Biosystems) with the following profile: 95°C 334 
denaturing (20 s) with 40 cycles of extension at 95°C (1 s) and 60°C (20 s). Each 335 
sample was analyzed in triplicate, and the cycle threshold (Ct) was averaged from the 336 
values obtained in each reaction. The results of the VCAM-1, E-selectin, ICAM-1 and 337 
MCP-1 mRNA expression are reported as the increase (x-fold) using a 2 – ΔΔCt 338 
mathematical method. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Applied 339 
Biosystems) was used as a housekeeping gene to normalize the results. TNF-α-activated 340 
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1, and the other conditions were about this reference value. The results are expressed as 342 
the mean and SD (error bars) of the changes in VCAM-1, E-selectin, ICAM-1 and 343 
MCP-1 mRNA about TNF-α alone. 344 
2.13. Stability of adhesion molecule mRNA after HT or HTmet incubation 345 
 Actinomycin D (Act D; Sigma-Aldrich, Spain) is an antineoplastic antibiotic 346 
isolated from Streptomyces sp bacteria that inhibits cell proliferation. Briefly, Act D is 347 
used as a transcription inhibitor because it inhibits the proliferation of cells in a non-348 
specific way by forming a stable complex with double-stranded DNA (via 349 
deoxyguanosine residues), thus inhibiting DNA-primed RNA synthesis (Siboni et al., 350 
2015). The half-life/stability of VCAM-1, ICAM-1, E-selectin and MCP-1 mRNA was 351 
measured after experimental incubations of HAECs. After 24 h of incubation with TNF-352 
α (10 ng/mL) and HT or HTmet (5 µM), Act D (5 µg/mL) was added to the medium of 353 
each experiment condition. The incubation times with Act D were 0, 30, 60, 120 and 354 
240 min. At these times, the cells were lysed to obtain the total RNA and processed 355 
following Section 2.9. The results were expressed as the mean and SD (error bars) of 356 
the changes in VCAM-1, ICAM-1, E-selectin and MCP-1 mRNA compared with time 0 357 
min for each experimental condition. 358 
2.14. MAPK proteome profiler array  359 
 In our experimental systems, we took advantage of the recently developed 360 
Human Phospho-MAPK Array from R&D Systems (Vitro, Madrid, Spain). It is a 361 
sensitive, semiquantitative and rapid tool for identifying the levels of phosphorylation 362 
of major mitogen-activated protein kinases (MAPKs): the extracellular-signal-regulated 363 
kinases (ERK1/ERK2), c-Jun N-terminal kinases (JNK 1–3), and different p38 MAPK 364 
isoforms (α, β, δ, and γ) and other intracellular kinases, such as Akt, glycogen synthase 365 
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allows the screening of multiple proteins without the need to carry out various 367 
immunoprecipitation and western blot analyses. 368 
Briefly, HAECs were rinsed with cold-PBS and immediately solubilized in 300 µL per 369 
10-cm dish of Lysis Buffer 6 provided in Human Phospho-MAPK Array by rocking the 370 
lysates gently at 4˚C for 30 min. After micro-centrifuging at 14,000 x g for 5 min, the 371 
supernatants were transferred to a clean test tube, and sample protein concentrations 372 
were determined using the Bradford protein assay (See total cellular protein 373 
quantification section). The lysates were then stored at -80ºC until the MAPK proteome 374 
profiler array analysis.  375 
The total cell lysates (200 µg of total protein per condition) were diluted and incubated 376 
according to the Human Phospho-MAPK Array manufacturer’s instructions. The array 377 
data were developed using a ChemiDoc Image System and semi-quantified with Image 378 
Lab analysis software (both from Bio-Rad Laboratories S.A., Barcelona, Spain). 379 
Densitometry values of the different phosphorylated molecules were obtained by 380 
subtracting negative control values to avoid the background, as recommended by the 381 
manufacturer. The results are expressed as the mean pixel density and SD. 382 
2.15. NF-B (p65) activity transcription factor assay    383 
 HAECs were washed twice with phosphate-buffered saline (PBS) purchased 384 
from Biowest (Labclinics, Barcelona, Spain). 300µL of hypotonic buffer (10mM 4-(2-385 
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.1 mM EDTA, 0.1mM 386 
ethylene glycol tetraacetic acid (EGTA), 10 mM potassium chloride, 0.75 mM 387 
Spermidine, 0.15 mM Spermine, 0.5% skimmed milk, 1mM dithiothreitol (DTT) and 388 
one tablet of protease inhibitor cocktail per 10 mL of hypotonic buffer solution) was 389 
added to each 10 cm dish. The cells were scraped with the cell lifter, and all the contents 390 
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a syringe BD Plastipak 305501 1ml Syringe with 26G x 0.5 (Bellés Diagnòstic i 392 
Investigació, S.L., Tarragona, Spain) 10 times to assure all the content was properly 393 
lysed. The samples were centrifuged at 16,000 x g for 10 min at 4ºC. The supernatants 394 
containing the cytoplasmic fraction were kept at -80ºC for future analysis. 395 
50 µL of extraction buffer (20 mM HEPES, 1 mM EDTA, 1 mM EGTA, 0.42 M 396 
sodium chloride; NaCl, 25% Glycerol, 1mM DTT and one tablet of protease inhibitor 397 
cocktail per 10 mL of extraction buffer solution) was added to the pellets and 398 
maintained at 4ºC for 45 min and mix-vortexed vigorously every 15 min. Then the 399 
samples were centrifuged at 16,000 x g for 1 h at 4ºC. The supernatants containing the 400 
nuclear extracts were stored at -80ºC until the quantification of the total cellular protein 401 
content and detection of NF-κB. 402 
Activation of the NF-κB (p65) from the nuclear extracts (5 µg of nuclear protein per 403 
condition, as recommended by the manufacture’s protocol) was measured using the NF-404 
κB (p65) Transcription Factor Assay Kit from Cayman Chemical (Vitro, Madrid, 405 
Spain). The activity of NF-κB p65-DNA binding was depicted as relative optical 406 
density (OD) at 450 nm / µg of protein.  407 
2.16. Total cellular protein quantification 408 
 To adjust the same quantity of protein for all the experimental conditions, the 409 
total cellular protein concentration from the cell lysates (nuclear lysates for NF-kB 410 
determination and total cellular lysates for MAPK proteome profiler) was determined 411 
using the Bradford protein assay from Bio-Rad with bovine serum albumin (BSA). A 412 
range of concentrations of BSA was used as the calibration standards for the protein 413 
assay. The absorbance was measured at 595 nm. 414 
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 All the experiments were performed at least twice, and each incubation 416 
condition was set up from three to eight replicates. One-way analysis of variance 417 
(ANOVA) followed by Bonferroni’s posthoc test was used for multiple comparisons. A 418 
value of p<0.05 was considered statistically significant. A requisite for the analytical 419 
quality of the model was the control of several aspects involved in the cellular process 420 
and analytical performance of measurements. All the results were analyzed with the 421 
Statistical Package for the Social Sciences (SPSS) software (version 22.0). The results 422 
are expressed as the mean (SD). 423 
3. Results 424 
3.1. Phenolic compliance biomarkers 425 
HT and its metabolites were measured in 24 h-urine and faeces in ApoE
-/-
 mice at the 426 
end of the experiment to monitor the phenolic compliance of the group supplemented 427 
with SEC extract. A significant increase in HT phase-II metabolites after SEC 428 
supplementation was observed in urine, the main metabolites detected being HT sulfate 429 
and homovanillic acid sulfate, confirming that the complex forms of OOPCs are mainly 430 
absorbed as HT (Supplementary Table 3). 431 
3.2. Serum lipid and glucose biomarkers   432 
There were no significant differences in the biochemical parameters of TC, TG, HDLc, 433 
LDLc and glucose in ApoE
-/-
 mice fed with 10 mg SEC/kg/day compared with the 434 
control group fed with the standard diet (Table 1). Moreover, no intra-group or inter-435 
group changes were observed between males or females. 436 
3.3. Atherosclerotic lesion in ApoE
-/- 
mice aorta 437 
The atherosclerotic plaques were analyzed in the entire aorta by Oil-Red-O staining in 438 
ApoE
-/-
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of SEC supplementation or control diet, none of the groups presented visible 440 
atherosclerotic lesions (Figure 1A).  441 
The atherosclerotic lesion in the aorta was further investigated more accurately by 442 
haematoxylin-eosin, Masson trichrome and Alcian blue staining for the presence of 443 
specific cell types and factors that could define the stages in the development of lesions. 444 
The histopathology staining revealed no significant differences between the control and 445 
the SEC treatment (Supplementary Figure 1). No differences were observed between 446 
males and females. 447 
3.4. Immunohistochemistry assay of VCAM-1, E-selectin, MCP-1, ICAM-1, and F4/80 448 
in ApoE
-/- 
in isolated mice aorta 449 
 Given the absence of atherosclerotic plaque, VCAM-1, E-selectin, MCP-1, and 450 
ICAM-1expression as molecular markers of endothelial dysfunction and F4/80 451 
expression as macrophage marker were studied by immunohistochemistry in ApoE
-/- 452 
aorta sections. Semi-quantitative analysis showed that the aortas from the SEC group 453 
had less staining of E-selectin, MCP-1, and ICAM-1 in the tunica intima, media and 454 
adventitia compared with the control group (p<0.05; Figures 1B, D, and E). VCAM-1 455 
and F4/80 staining was also less intensive in the SEC group in the tunica intima and 456 
adventitia compared with the control group (p<0.05; Figure 1C and F) but not in the 457 
tunica media. The positive-staining cells for F4/80 were considered to be infiltrating 458 
macrophages. 459 
3.5. HAEC cytotoxicity 460 
For the in-vitro assays with HAEC, the native form of HT and a mixture of its plasmatic 461 
metabolites (HTmet) obtained as previously reported (Catalán et al., 2015) were tested 462 
at physiological concentrations. There was no evidence of HAEC cytotoxicity following 463 
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α (10 ng/mL) for 24 h. No difference was measured in the activity of LDH release 465 
compared with the TNF-α (10 ng/mL) treatment alone, confirming that HT and HTmet 466 
are not cytotoxic at the concentrations and times tested. These results were reported in a 467 
previous study by Catalán et al. (Catalán et al., 2015). 468 
3.6. Effect of HT or HTmet on Lymphocyte Cell Adhesion to HAECs 469 
Qualitatively, very few lymphocyte Jurkat T cells adhered to untreated HAECs 470 
(Figures 2A and B) whereas a considerable number of cells adhered to HAECs after 471 
the TNF-α (10ng/mL) treatment (Figure 2C). Lymphocyte adhesion to HAECs co-472 
incubated with HT or HTmets at 1, 2 and 5 µM with TNF-α appeared to decrease 473 
compared with the condition of HAECs only treated with TNF-α. Co-incubation of 474 
HTmets and TNF-α seemed to decrease greatly compared with HT at all concentrations 475 
tested (Figure 2G, H and I versus D, E, and F). 476 
These qualitatively results seem to be confirmed by the cell fluorescence images, which 477 
revealed that exposure of HAECs to HTmet at 1, 2 and 5 µM reduced the adhesion of 478 
the Jurkat T cells significantly by 11.0, 10.3 and 54.2% respectively compared with 479 
TNF-α alone (Figure 2K). HT also reduced the adhesion of lymphocytes to HAECs 480 
significantly at 1, 2 and 5 µM, but to a lesser extent of 5.1, 11.3 and 3.5% respectively 481 
(Figure 2J). Comparing the HT and HTmet treatments, as observed qualitatively, the 482 
HTmet produced a greater percentage reduction of lymphocyte adhesion than HT at 1 483 
and 5 µM (Figure 2K). 484 
3.7. Effect of HT or HTmet on E-selectin, ICAM-1, VCAM-1 and MCP-1 mRNA 485 
expression by HAECs  486 
In our previous study (Catalán et al., 2015), after observing a significant decrease in E-487 
selectin, ICAM-1, VCAM-1, P-selectin and MCP-1 protein secretion after the exposure 488 



































































21 of 41 
greater depth and determine the mRNA expression of these molecules (Figure 3). At 490 
lower concentrations (0.5, 1 and 2 µM), neither HT, HTmets nor modified mRNA 491 
levels compared with TNF-α alone. As shown in Figures 3A and B, HTmet only 492 
reduced E-selectin and VCAM-1 mRNA expression significantly at 5 µM, by 493 
approximately 44 and 40% (p<0.05), respectively. HTmets also reduced ICAM-1 494 
mRNA expression by 32%, but this reduction was not statistically significant (Figure 495 
3C). We also observed a decrease in MCP-1 mRNA expression after HT exposure at the 496 
highest concentration of 5 µM but in a non-significant way (Figure 3D). 497 
3.8. Effect of HT and HTmet on VCAM-1, ICAM-1, E-selectin and MCP-1 mRNA 498 
kinetic stability in HAEC cells using the RT-PCR assay  499 
The results from the kinetic measurement of mRNA stability from 0 to 240 min in 500 
HAEC cells, showed that VCAM-1, ICAM-1, E-selectin and MCP-1 mRNA levels fell 501 
progressively from the starting point (time 0 min) and reached the minimum level at 502 
120 min and remained stable until 240 min under all test conditions (Supplementary 503 
Figure 2). No significant differences between HT and HTmet in TNF-α, VCAM-1 and 504 
E-selectin mRNA levels were observed at 5 µM. The pattern for HT was similar to 505 
TNF-α alone in stabilizing VCAM-1, ICAM-1, E-selectin and MCP-1 mRNA 506 
expression (Supplementary Figures 2A, B, C, and D, respectively), and showed no 507 
differences between any molecules at any time. However, HTmet stabilized ICAM-1 508 
mRNA at 120 min and MCP-1 mRNA at 30 and 120 min, compared with TNF-α alone 509 
(p<0.05; Supplementary Figures 2B and D). HTmet stabilized MCP-1 mRNA 510 
expression at 30 min more than HT (p<0.05; Supplementary Figure 2D). 511 
3.9. Effect of HT and HTmet on the MAPK family and NF-κB activity in HAEC cells 512 
After performing the proteome array, we identified at the same time the activation status 513 
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(α, β, δ, and γ) as well as other intracellular kinases, such as Akt, GSK-3, p70 S6 515 
Kinase, TOR, p53 and CREB in whole-cell lysates from HAECs. 516 
 517 
The transcription factors Akt1, Akt2, Akt pan, GSK-3α/β, GSL-3β, HSP27, JNK1, 518 
MSK2, RSK1, RSK2, and TOR showed no significant modulation after HAEC 519 
exposure to HT or HTmet at 5 µM (data not shown). 520 
 521 
The representative array results of the spot membranes are shown in Figures 4A 522 
(Blank), 4B (TNF-α 10 ng/mL), 4C (HT 5µM + TNF-α 10 ng/mL) and 4D (HTmet 5 523 
µM + TNF-α 10 ng/mL). Figure 4E shows the pixel density of the transcription factors 524 
that HT or HTmet were able to reduce compared with the TNF-α condition. The results 525 
indicate that, compared with the TNF-α condition, at 5µM, HT and HTmet significantly 526 
decreased CREB (11.09 and 11.99% respectively), JNK pan (JNK 1-3; 18.5 and 527 
27.55% respectively), p38δ (23.73 and 33.73% respectively) and p70 S6 Kinase (28.64 528 
and 32.20 % respectively). As observed, the percentage reductions of those molecules 529 
were greater with HTmet than the HT condition, but those differences were not 530 
significant. HT and HTmet also reduced the ERK1 (6.87 and 5.39% respectively), 531 
MKK3 (11.63 and 39.87% respectively), MKK6 (2.18 and 31.23% respectively) and 532 
p38β (18.79 and 17.64% respectively) molecules compared with the TNF-α condition. 533 
However, these reductions were not significant. 534 
The HT condition reduced significantly p38α (21.66%) and p38γ (29.48%) 535 
compared with TNF-α (p<0.05) while HTmet did not reduce those molecules. The latter 536 
reduced Akt3 (31.10%), JNK2 (45.28%) and p53 (27.22%) compared with TNF-α alone 537 
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The NF-κB p65 activation showed that TNF-α (10 ng/mL) increased the activity 539 
10-fold compared with blank (control condition) demonstrating a proper stimulation of 540 
the cells (p<0.05). HT or HTmet at 5 µM showed no significant difference in p65-NF-541 
κB activation compared with TNF-α alone (Supplementary Figure 3). 542 
4. Discussion 543 
The improvement of the endothelial function with OOPCs as a way of protecting 544 
against atherosclerosis has been described in several human studies (Moreno-Luna et 545 
al., 2012; J. Ruano et al., 2005; Valls et al., 2015). Considering the great metabolism 546 
these compounds undergo when absorbed, in this study we report novel potential 547 
mechanisms of main plasmatic HT phase-II metabolites for attenuating the initial steps 548 
of atherosclerosis for the first time using a translational approach with in-vitro and in-549 
vivo experiments. 550 
Initially, the effect of OOPCs on the endothelial function of ApoE 
-/-
 mice was 551 
tested by supplementing their diet with a phenolic extract rich in SEC. The compliance 552 
of the group with the diet supplemented with the SEC extract was corroborated by 553 
measuring 24 h-urine and faeces in the ApoE
-/-
 mice at the end of the experiment. A 554 
significant increase in the main HT phase-II metabolites (HT sulfate and homovanillic 555 
acid sulfate) was observed in the urine of mice after supplementing their diet with SEC. 556 
Those results were corroborated by Khymenets et al. in humans who demonstrated that 557 
HT is bioavailable and can be recovered in the urine as HT sulfate (Khymenets et al., 558 
2016). Given that a standard diet was used instead of a high-fat diet, atherosclerotic 559 
development was very limited in both the SEC and control groups after 12 weeks. The 560 
high-fat diet significantly accelerates atherogenesis in ApoE 
-/-
 model and induces the 561 
formation of the advanced lesions containing necrotic cellular cores and fibrous caps as 562 



































































24 of 41 
we aimed to test the potential role of a diet supplemented with nutritionally appropriate 564 
doses of OOPCs without any pro-inflammatory diet, given that a high-fat diet represents 565 
a toxic proinflammatory stimulus rather than a low and chronic inflammatory state in 566 
animals (Okada et al., 2013). Due to this and the low doses of OOPCs administered, no 567 
differences were found in the plasmatic lipid profile, lipid accumulation, collagen and 568 
proteoglycan deposition and the integrity of the aorta in SEC group compared with the 569 
control group in the ApoE 
-/-
 mice model. These results are in line with previous studies 570 
conducted by Acín S et al. (Acín et al., 2006) who found no significant changes in 571 
HDLc, paraoxonase, apolipoprotein B or triglyceride levels although they observed a 572 
decrease in apolipoprotein A-I and an increase in the total cholesterol, atherosclerotic 573 
lesion areas and circulating monocytes expressing Mac-1 after HT administration in 574 
ApoE
-/-
 deficient mice fed with a chow diet for 10 weeks. The levels of LDLc observed 575 
in our study seems to be higher in the SEC group than in the control group,  however, 576 
this difference did not reach statistical significance. May be increasing the number of 577 
animals may decrease the SD, a result also observed by Acín S et al. where LDLc 578 
where significantly higher in polyphenol group compared to control group (Acín et al., 579 
2006). Notwithstanding, when we assessed the molecular levels of the VCAM-1, E-580 
selectin, MCP-1, and ICAM-1 protein expression in the tunica intima, media, and 581 
adventitia of isolated mice aortas after 12 weeks of treatment, these molecules 582 
decreased significantly in the SEC group compared with the control group, suggesting 583 
attenuation at the molecular level in the initial steps of atherosclerosis. In the same line, 584 
Katsarou et al. observed that the phenolic constituents of VOO reduced the E-selectin 585 
and VCAM-1 molecules in the aorta of rats (Katsarou et al., 2015). Moreover, the 586 
detection of F4/80 (a macrophage marker) expression in the isolated aortas of the ApoE
-587 
/-
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roots in the control group and in SEC group F4/80 where significantly decreased 589 
showing less macrophages distributed in the aorta section. Result within accordance to 590 
Lin et al., where observed an increase of the number of macrophages present within 591 
lesions compared to the control group (Lin et al., 2015).  592 
 To study the implication of HT and its biological metabolites on the intracellular 593 
pathways of VCAM-1, ICAM-1, E-selectin and MCP-1 molecules secretion, we 594 
performed an experiment with HAECs using a mix of HTmet at doses similar to that 595 
previously detected in human plasma after the ingestion of VOO (Rubió et al., 2014). 596 
For this purpose, we chose an adhesion functional assay simulating the physiological 597 
conditions of the first stages of atherosclerosis when leukocytes (monocytes and/or 598 
lymphocytes) are attracted to the endothelial cells due to the secretion of endothelial 599 
dysfunction molecules secreted by inflammatory cytokines, such as TNF-α (Libby, 600 
Ridker, & Hansson, 2011). The functional study showed that both HT and HTmet 601 
reduced the adhesion of the lymphocytes to HAECs at all concentrations tested, with 602 
significantly greater reductions with HTmet. These results suggest an active role of the 603 
circulating HTmet in attenuating the lymphocyte adhesion process.  No previous studies 604 
have conducted a functional adhesion assay with OOPCs but similar experiments 605 
performed with other antioxidant compounds, such as alpha-tocopherol, also inhibited 606 
the adhesion of Jurkat T lymphocytes to HAECs (Catalán et al., 2012; Koga, 607 
Claycombe, & Meydani, 2002). 608 
After the functional study, in order to gain insight into the intracellular 609 
mechanisms of VCAM-1, ICAM-1, E-selectin, and MCP-1, we assessed their mRNA 610 
expression and stability, and the modulation of the MAPK family and NF-κB 611 
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summarized in Table 2. This table reflects greater overall effects with HTmet rather 613 
than the native form of HT and also shows different pathway modulation. 614 
The reduction of E-selectin, ICAM-1, and VCAM-1 mRNA expression by 615 
HTmet agreed with our previous experiments in which we reported that the protein 616 
expression of these molecules was significantly inhibited by HTmet in HAECs (Catalán 617 
et al., 2015). The present mechanistic studies have shown that the mRNA and protein 618 
reduction by HTmet could be regulated by the MAPK pathway but not by the NF-κB 619 
pathway. Particularly, HTmet significantly reduced the phosphorylation of p38δ, JNK1-620 
3, CREB, AKT3, p53 and P70 S6 Kinase. These results suggest that VCAM-1, ICAM-621 
1, and E-selectin could be regulated by HTmet at the beginning of the pathway through 622 
the inhibition of the MAPK transcription factors with a consequent inhibition of the 623 
mRNA and protein secretion (Figure 5). 624 
On the other hand, the HTmet had no effects on MCP-1 mRNA expression, 625 
indicating that HTmet could inhibit MCP-1 protein expression at the post-626 
transcriptional level. Hence, MCP-1 synthesis could be governed by multiple factors, 627 
such as post-transcriptional modifications occurred in the nucleus, the cytoplasm or 628 
both, or by post-translational modifications produced at the cytoplasm level. A possible 629 
post-transcriptional mechanism of MCP-1 regulation that could explain that 630 
disagreement on mRNA and protein secretion shown recently by Tomé-Carneiro et al. 631 
(Tomé-Carneiro et al., 2017) could be also be explained by small noncoding RNAs 632 
(micro-RNAs; miRNA). Indeed, it has been reported that the increase in TNF-α 633 
downregulates miR-122 causes the upregulation of MCP-1 (Li et al., 2016). Another 634 
study performed on human umbilical vein endothelial cells (HUVEC) indicated that the 635 
decrease in miR-495 upregulates MCP-1 (Liu et al., 2015). Other miRNA targets, such 636 
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which could be decreased by HTmet incubation. Moreover, possible MCP-1 post-638 
translational modifications could be due by sulfated modifications on chemokine 639 
receptors on tyrosine residues in their N-terminal regions, the initial site of binding to 640 
MCP-1 chemokine ligands. Tan et al. demonstrated that the interaction with the sulfated 641 
N-terminus of chemokine receptor type 2 (CCR2) destabilizes the dimerization interface 642 
of inactive dimeric MCP-1, thus inducing dissociation from the active monomeric state 643 
(Tan et al., 2013).  644 
Regarding the effects of HT, the results showed that the native structure of HT 645 
could reduce some molecules of the MAPK pathway significantly (p38 α, δ and γ, 646 
CREB, P70 S6 Kinase and JNK1-3). However, the results indicated a less efficient 647 
modulation of the MAPK pathway compared with HTmet, which could be the reason 648 
for the non-modulation of the mRNA expression of the adhesion molecules (Figure 5). 649 
Despite that, in our previous study, we observed a reduction in the protein secretion of 650 
E-selectin, P-selectin, ICAM-1, and VCAM-1 adhesion molecules by HT (Catalán et 651 
al., 2015), suggesting other HT mechanisms apart from those studied here. In agreement 652 
with our results, Dell’Agli et al. showed the effects of HT on the reduction of E-selectin 653 
protein secretion, with no changes in E-selectin mRNA expression in HUVEC 654 
(Dell’Agli et al., 2006), whereas they did not present any possible mechanism to explain 655 
this controversy. Differential mRNA expression-protein studies have demonstrated the 656 
poor correlation between mRNA and protein expression levels (Koussounadis, 657 
Langdon, Um, Harrison, & Smith, 2015). Indeed, only 40% of the variation in protein 658 
concentration can be explained by the abundance of mRNA (Vogel & Marcotte, 2012). 659 
To explain the remaining 60% of the variation, gene ontology theme enrichment 660 
analysis indicated that the genes with high correlations between RNA-protein 661 
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properties (Gry et al., 2009). Therefore, we suggest a possible different mechanism than 663 
HTmet related to post-transcriptional or post-translational modifications by HT to 664 
explain the discordance observed in this study between the mRNA and protein secretion 665 
of adhesion molecules with HT treatment. 666 
As we observed in our study, HAECs represent a direct target for studying the 667 
action of bioactive molecules once these are absorbed in the blood stream where they 668 
probably regulate the adhesion protein expression by transcriptional and 669 
posttranscriptional mechanisms. The data obtained provide new mechanistic insights 670 
that could partly explain the improvement in the endothelial dysfunction by OOPCs 671 
observed in humans, highlighting that the HT biological metabolites circulating in 672 
plasma after absorption could be the main contributors to this effect. Thus, our results 673 
complement the hypothesis in Muto et al. that “olive oil phenols also act through 674 
pathways others than NF-κB” (Muto et al., 2015) which is corroborated by our study 675 
and others (Aparicio-Soto et al., 2016). 676 
In conclusion, the supplementation with OOPCs at nutritionally relevant doses 677 
showed a mild attenuation of the initial steps of atherosclerosis through the reduction of 678 
endothelial dysfunction biomarkers E-selectin, VCAM-1 and MCP-1 in the tunica 679 
intima, media, and adventitia of the aorta of ApoE 
-/-
 mice fed without a pro-680 
inflammatory diet. This inhibition could be mainly explained by the action of the 681 
plasmatic circulating HTmet as they were more efficient than the native structure of HT 682 
at plasmatic physiological concentrations in the reduction of lymphocyte adhesion and 683 
the modulation of the MAPK pathway in endothelial cells. Thus, for the first time, the 684 
present study reveals the plasmatic circulating metabolites of HT could have an 685 
important role in preventing the endothelial dysfunction, indicating that this process 686 
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 883 
Figure captions 884 
Figure 1. Representative Immunohistochemistry staining for E-selectin, VCAM-1 and 885 
MCP-1 in ApoE-/- mouse aortic sections. (A) Representative images of oil red stained 886 
transversal-sections from Control and SEC Apo E-/- mice aorta samples. Aorta semi-887 
quantitative analysis of E-selectin (B), VCAM-1 (C), MCP-1 (D), ICAM-1 (E), and 888 
F4/80 (F) staining (see Materials and Methods Section). The data are expressed as the 889 
mean (standard deviation; SD) of the scores obtained for The effect tunica intima, 890 
media and adventitia of the aortic wall for each molecule stained. *p <0.05 SEC 891 
compared with the Control group. 892 
 893 
Figure 2. Images of the adhesion of Jurkat T cells to TNF-α-treated HAEC under 894 
microscope (X4 and X10) in the experiments (A-I). The conditions for this study were: 895 
A) hydroxytyrosol (HT) vehicle control (H2O); B) HT metabolites (HTmet) vehicle 896 
control (MetOH); C) TNF-α (10 ng/mL); co-incubation of D-F) HT or G-I) HTmet (1, 2 897 
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(RFU) corresponding to each condition in the experiment.*p < 0.05 versus TNF-α 899 
alone. †p<0.05 compared between HT and HTmet at the same concentration. 900 
 901 
Figure 3. The effect of HT or HTmet (0.5, 1, 2 and 5 µM) on E-selectin, VCAM-1, 902 
ICAM-1 and MCP-1 mRNA expression in HAECs stimulated by TNF-α (10ng/mL) for 903 
24h. A) The effect of HT or HTmet on E-selectin mRNA expression. B) The effect of 904 
HT or HTmet on VCAM-1 mRNA expression. C) The effect of HT or HTmet on 905 
ICAM-1 mRNA expression. D) The effect of HT or HTmet on MCP-1 mRNA 906 
expression. The results are the mean and the standard deviations (SD; error bars) of two 907 
independent experiments where each set of experimental conditions was run in 908 
triplicate. *p < 0.05 versus TNF-α alone. 909 
 910 
Figure 4. The effect of hydroxytyrosol (HT) and HT metabolites (HTmet) on the 911 
phosphorilation status of all three major families of mitogen-activated protein kinases 912 
(MAPKs): the extracellular signal-regulated kinases (ERK 1/2), c-Jun N-terminal 913 
kinases (JNK 1-3) and different p38 isoforms (α/β/δ/γ) in human aortic endothelial 914 
cells. A-D) The templates showing the location of MAPK antibodies spotted onto the 915 
membrane of Human Phospho-MAPK Array Kit: A) blank cells; B) TNF-α (10ng/mL); 916 
C) HT (5µM) + TNF-α (10ng/mL); D) HTmet (5µM) + TNF-α (10ng/mL). E) The 917 
densitometry values of the different phosphorylated molecules were obtained by 918 
subtracting negative control values in order to avoid the background, as recommended 919 
by manufacturer. The data are expressed as the mean of the pixel density and SD (error 920 
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Figure 5. Graphic representation summarizing the suggested intracellular mechanisms 923 
of the action of hydroxytyrosol (HT) and its main plasmatic metabolites (HTmet) in the 924 
attenuation of atherosclerosis. † p<0.001 versus HT. 925 
 926 
Supplementary Figure 1. Different staining of sections of ApoE
-/-
 mice aorta after the 927 
control and secoiridoid (SEC) treatments to measure the atherosclerotic 928 
burden. A) Alcian blue staining (proteoglycan deposition); B) Hematoxylin eosin 929 
staining (integrity of aorta); C) Masson tricromic staining (fibrosis). 930 
 931 
Supplementary Figure 2.  The effect of HT and HTmet on VCAM-1, ICAM-1, E-932 
selectin and MCP-1 mRNA stabilization in HAECs using the RT-PCR assay. The 933 
HAECs were incubated with TNF-α alone (10 ng/ml), HT or HTmet (5 µM) and TNF-934 
α (10 ng/mL) for 24h. The incubation times with Act D were 0, 30, 60, 120 and 240 935 
min. At these times, the cells were lysed to obtain the total RNA. The data were 936 
normalized using the values obtained from the GAPDH (housekeeping gene), and are 937 
the mean of two separate experiments run in triplicate. The error bars show the SD. *p < 938 
0.05 versus TNF-αalone (10 ng/mL). †p<0.05 HTmet compared with HT at the same 939 
concentration. 940 
  941 
Supplementary Figure 3.  The effect of HT and HTmet on the activity of NF-κB p65-942 
DNA binding in human aortic endothelial cells. The data are expressed as the relative 943 






















































































































































Table 1. Biochemical parameters in ApoE
-/- 








 secoiridoid group 





































































10.62 (2.83)  
 
>0.050 >0.050 
LDL   254.84 (49.48)   231.19 (31.16) 
 
  358.35 (64.82)   272.95 (28.98)  
 
>0.050 >0.050 
                  HDL, high-density lipoprotein; LDL, low-density lipoprotein 
   LDL was calculated by Friedewald formula. 
One-way analysis of variance (ANOVA) followed by Bonferroni’s posthoc test was used for multiple comparisons. A value of p<0.05 





Table 2. Summary of the results obtained after hydroxytyrosol and hydroxytyrosol metabolites incubation. 
  
Concentrations 
tested (µM)   
Hydroxytyrosol Hydroxytyrosol metabolites 
MAPK pathway 5 
  
↓p38 α*, p38δ*, p38γ*, JNK1-3*, 
CREB* and P70 S6 Kinase*  
(↓p38β, Akt3, p53 and ERK1) 
↓p38 δ*, JNK1-3*, CREB*, Akt3*, 
P70 S6 Kinase* and p53*  
(↓p38β and ERK1) 
NF-ΚB pathway 5   ↓ NE 
mRNA quantification 0.5, 1, 2 and 5  
VCAM-1 NE ↓ 5µM* (↓ 0.5-2 µM) 
ICAM-1 NE ↓ 1-5 µM 
E-selectin NE ↓ 5µM* 
P-selectin - - 
MCP-1 ↓ 5µM ↑ 2-5µM* 
mRNA stability 5 
VCAM-1 NE NE 
ICAM-1 NE ↑120 min* 
E-selectin NE NE 
P-selectin - - 
MCP-1 NE ↑30 and 120 min* 
Protein secretion 1, 2, 5 and 10  
VCAM-1 ↓ 1-10µM* ↓ 2-10µM* 
ICAM-1 ↓ 1-10µM* ↓ 2-10µM* 
E-selectin ↓ 1-10µM* ↓ 2-10µM* 
P-selectin ↓ 1-10µM* ↓ 2-10µM* 
MCP-1 NE ↓ 5-10µM* 
Cell-cell adhesion 1, 2 and 5   ↓ 1-5µM* ↓ 1-5µM*
†
 
     NE, no effects. 
* p<0.05 versus TNF-α alone. 
 † 
p<0.001 versus HT. 
Table 2
Supplemental Table 1. Composition of SEC extract 
(mg/L) obtained after pressurized liquid extraction from 
olive cake followed by SPE purification.  
 
p-HPEA-EDA, dialdehydic form of elenolic acid linked to 
tyrosol; 3,4-DHPEA-EDA, dialdehydic form of elenolic 
acid linked to hydroxytyrosol; p-HPEA-EA, aldehydic 
form of elenolic acid linked to tyrosol; 3,4-DHPEA-EA, 
isomer of oleuropein aglycone.  
Values are expressed as mean ± SD (n=3). 
Compound mg/L of extract 
Tyrosol 625.3 ± 60.0 
Hydroxytyrosol  4779.2 ± 101.5 
Hydroxytyrosol Acetate 70.2 ± 1.9 
Elenolic acid 1529.6 ± 11.5 
p-HPEA-EDA 0.3 ± 0.02 
3,4-DHPEA-EDA 3358.6 ± 185.4 
Ligstroside derivate 177.1 ± 2.1 
p-HPEA-EA 1.2 ± 0.1 
Oleuropein derivate 78.1 ± 3.2 
3,4-DHPEA-EA 33.5 ± 2.4 
Oleuropein 109.5 ± 2.6 
Supplemental Table 1
Supplemental Table 2. SRM conditions for the analysis of hydroxytyrosol metabolites by UPLC-MS/MS. 
Phenolic compound 
Quantification (SRM1) Identification (SRM2) 











Hydroxytyrosol 153  123 35 10 153  95 35 25 Hydroxytyrosol 
Hydroxytyrosol sulfate 233  153 40 15 233  123 40 25 Hydroxytyrosol-3-O-sulfate 
Hydroxytyrosol disulfate 313  233 40 10 313  153 40 30 Hydroxytyrosol-3-O-sulfate 
Hydroxytyrosol-3-O-glucuronide 329  153 40 20 329  123 40 25 Hydroxytyrosol 
Hydroxytyrosol-4-O-glucuronide 329  153 40 20 329  123 40 25 Hydroxytyrosol 
Homovanillic alcohol 167  152 35 15 167  122 35 25 Hydroxytyrosol 
Homovanillic alcohol sulphate 247  167 40 15 247  152 40 25 Hydroxytyrosol 
Homovanillic alcohol glucuronide 343  167 40 20 343  152 40 35 Hydroxytyrosol 
Homovanillic acid 181  137 25 10 181  122 25 15 Hydroxytyrosol 
Homovanillic acid sulphate 261  181 40 15 261  137 40 25 Hydroxytyrosol 
Homovanillic acid glucuronide 357  181 40 20 357  137 40 30 Hydroxytyrosol 
Hydroxytyrosol acetate sulphate 275  153 35 15 275  123 35 30 Hydroxytyrosol 
Elenolic acid 241  139 30 15 241  127 30 20 Hydroxytyrosol 
Elenolic acid sulphate 321  241 40 15 321  139 40 20 Oleuropein 
Elenolic acid glucuronide 417  241 40 15 417  139 40 20 Oleuropein 
Oleuropein  539  377 35 15 539  275 35 20 Oleuropein 
Oleuropein glucuronide 715  539 55 15 715  377 55 25 Oleuropein 
Oleuropein aglycone sulfate 457  377 40 15 457  275 40 20 Oleuropein 
Oleuropein aglycone glucuronide 553  377 40 15 553  377 40 20 Oleuropein 
Methyl oleuropein aglycone sulfate 471  391 40 15 391  275 40 20 Oleuropein 
Oleuropein aglycone derivate 1 555  523 40 15 555  275 40 25 Oleuropein 
Oleuropein aglycone derivate 2 571  539 40 15 571  377 40 25 Oleuropein 
Catechol  108.9  90.9 40 15 - - - Catechol  
Phenylacetic acid 135  91 20 5 - - - p-Hydroxyphenylacetic acid  
Hydroxyphenylacetic acid 151  107 20 10 - - - p-Hydroxyphenylacetic acid 
Hydroxyphenylacetic acid sulphate 231  151 20 20 231  107 20 25 p-Hydroxyphenylacetic acid 
Hydroxyphenylacetic acid glucuronide 327  151 20 15 327  107 20 25 p-Hydroxyphenylacetic acid 
Dihydroxyphenylacetic acid 167  123 20 10 - - - 3,4-Dihydroxyphenylacetic acid 
Hydroxybenzoic acid 137  93 30 15 - - - p-Hydroxyphenylacetic acid 
Protocatechuic acid 153  109 45 15 - - - Hydroxytyrosol  
Hydroxyphenylpropionic acid 165  121 20 10 - - - 3-(4-Hydroxyphenyl)propionic acid 
Hydroxyphenylpropionic acid sulphate 245  165 35 15 245  121 35 20 3-(4-Hydroxyphenyl)propionic acid 
Dihydroxyphenylpropionic acid 181  137 20 15 - - - 3-(4-Hydroxyphenyl)propionic acid 
Hippuric acid 178  134 40 10 - - - Hippuric acid 









n.d., not detected; n.q., not quantified; HT, hydroxytyrosol; OH, hydroxy; S, sulfate; G, 
glucuronide; ac, acid. 
Results are expressed as mean ± s.d.  
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HT acetate S 0.00±0.00 0.01±0.00  0.00±0.00 0.05±0.04 
Fecal biomarkers ApoE
-/-
 male  ApoE
-/-
 female 
(nmol/g fresh feces) Control SEC  Control SEC 
Phenylacetic ac 23.66±11.07 39.86±16.25*  6.75±4.72 9.97±7.71* 
OHphenylacetic ac 93.85±17.40 159.9±34.78*  125.3±16.63 138.5±17.36* 
HT n.d. 11.64±6.12  n.d. 14.15±10.4 
OHPhenylpropionic ac 14.16±3.08 32.01±7.44*  18.89±3.81 30.20±7.00* 
diOHphenylacetic ac n.d. 20.08±18.4  n.d. 8.09±6.43 
Hippuric ac 67.37±10.55 110.1±84.6*  45.89±25.25 85.67±73.19 
Tyrosol S 3.03±2.06 17.0±10.0*  n.d. 21.82±25.00 
OHphenylacetic ac S 39.47±41.47 124.0±68.3*  21.10±13.00 49.03±21.71* 
HT S n.d. 30.67±57.50  n.d. 12.70±4.05 
OHPhenylpropionic ac S 175.9±12.6 260.8±196.7  194.7±140.3 162.2±133.35* 
Homovanillic ac S 39.61±47.42 143.1±44.0*  18.16±12.33 28.62±22.47* 
DiOHPhenylpropionic ac S n.d. 17.74±32.02  n.d. 36.11±86.98 
HT acetate S n.d. 40.56±31.42  n.d. 16.85±9.12 
Catechol S 25.23±17.48 31.51±11.21*  11.76±8.19 84.48±47.55* 
Methyl catechol S 7.17±14.34 101.2±34.79*  n.q. 76.46±67.60 
Coumaric acid S 26.85±1.98 37.38±4.52*  21.67±8.92 40.00±10.47* 
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